Ver registro no DEDALUS
Exportar registro bibliográfico

Metrics


Metrics:

Association between BanI genotype and increased phospholipase A2 activity in schizophrenia (2007)

  • Authors:
  • USP affiliated authors: VALLADA FILHO, HOMERO PINTO - FM ; GATTAZ, WAGNER FARID - FM
  • USP Schools: FM; FM
  • DOI: 10.1007/s00406-007-0736-0
  • Subjects: GENÓTIPOS; FOSFOLIPASES A; POLIMORFISMO; ESQUIZOFRENIA (ATIVIDADE)
  • Language: Inglês
  • Imprenta:
  • Source:
  • Acesso online ao documento

    DOI or search this record in
    Informações sobre o DOI: 10.1007/s00406-007-0736-0 (Fonte: oaDOI API)
    • Este periódico é de assinatura
    • Este artigo NÃO é de acesso aberto
    • Cor do Acesso Aberto: closed
    Informações sobre o Citescore
  • Título: European Archives of Psychiatry and Clinical Neuroscience

    ISSN: 0940-1334

    Citescore - 2017: 2.93

    SJR - 2017: 1.574

    SNIP - 2017: 1.018


  • Exemplares físicos disponíveis nas Bibliotecas da USP
    BibliotecaCód. de barrasNúm. de chamada
    FM1832913-10BCSEP 104 2007
    How to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      BARBOSA, Nadia R.; JUNQUEIRA, Ricardo M.; VALLADA FILHO, Homero P.; GATTAZ, Wagner Farid. Association between BanI genotype and increased phospholipase A2 activity in schizophrenia. European Archives of Psychiatry and Clinical Neuroscience, Darmstadt, v. 257, p. 340-343, 2007. DOI: 10.1007/s00406-007-0736-0.
    • APA

      Barbosa, N. R., Junqueira, R. M., Vallada Filho, H. P., & Gattaz, W. F. (2007). Association between BanI genotype and increased phospholipase A2 activity in schizophrenia. European Archives of Psychiatry and Clinical Neuroscience, 257, 340-343. doi:10.1007/s00406-007-0736-0
    • NLM

      Barbosa NR, Junqueira RM, Vallada Filho HP, Gattaz WF. Association between BanI genotype and increased phospholipase A2 activity in schizophrenia. European Archives of Psychiatry and Clinical Neuroscience. 2007 ; 257 340-343.
    • Vancouver

      Barbosa NR, Junqueira RM, Vallada Filho HP, Gattaz WF. Association between BanI genotype and increased phospholipase A2 activity in schizophrenia. European Archives of Psychiatry and Clinical Neuroscience. 2007 ; 257 340-343.

    Referências citadas na obra
    American Psychiatric Association (1994) Diagnostic and statistical manual of mental disorders, 4th edn. American Psychiatric Press, Washington, DC
    Barradas MA, Mikhailidis DP (1993) The use of platelets as models for neurons: possible applications to the investigation of eating disorders. Biomed Pharmacother 47:11–18
    Chowdari KV, Brandstaetter B, Semwal P, Bhatia T, Deshpande S, Reddy R, Wood J, Weinberg CR, Thelma BK, Nimgaonkar VL (2001) Association studies of cytosolic phospholipase A2 polymorphisms and schizophrenia among two independent family-based samples. Psychiatr Genet 11:207–212
    Clark JD, Lin LL, Kriz RW, Ramesha CS, Sultzman LA, Lin AY, Milona N, Knopf JL (1991) A novel arachidonic acid-selective cytosolic PLA2 contains a Ca(2+)-dependent translocation domain with homology to PKC and GAP. Cell 65:1043–1051
    Di Luca M, Colciaghi F, Pastorino L, Borroni B, Padovani A, Cattabeni F (2000) Platelets as a peripheral district were to study pathogenetic mechanisms of Alzheimer disease: the case of amyloid precursor protein. Eur J Pharmacol 405:277–283
    Frieboes RM, Moises HW, Gattaz WF, Yang L, Li T, Liu X, Vetter P, Macciardi F, Hwu HG, Henn F (2001) Lack of association between schizophrenia and the phospholipase-A (2) genes cPLA2 and sPLA2. Am J Med Genet 105:246–249
    Gattaz WF, Kollisch M, Nevalainen TJ, Thuren T, Kinnunen PKJ (1987) Increased plasma phospholipase-A2 activity in schizophrenia: reduction after neuroleptic therapy. Biol Psychiatry 22:421–426
    Gattaz WF, Hubner CK, Nevalainen TJ, Thuren T, Kinnunen PKJ (1990) Increased serum phospholipase-A2 activity in schizophrenia: a replication study. Biol Psychiatry 28:495–501
    Gattaz WF, Schmitt A, Maras AM (1995) Increased platelet phospholipase A2 activity in schizophrenia. Schizophr Res 16:1–6
    Glen AI, Glen EM, Horrobin DF, Vaddadi KS, Spellman M, Morse-Fisher N, Ellis K, Skinner FS (1994) A red cell membrane abnormality in a subgroup of schizophrenic patients: evidence for two diseases. Schizophr Res 12:53–61
    Horrobin DF (1998) The membrane phospholipid hypothesis as a biochemical basis for the neurodevelopmental concept of schizophrenia. Schizophr Res 30(3):193–208
    Horrobin DF, Bennett CN (1999) New gene targets related to schizophrenia and other psychiatric disorders: enzymes, binding proteins and transport proteins involved in phospholipid and fatty acid metabolism. Prostaglandins Leukot Essent Fatty Acids 60:111–167
    Hudson CJ, Kennedy JL, Gotowiec A, Lin A, King N, Gojtan K, Macciardi F, Skorecki K, Meltzer HY, Warsh JJ, Horrobin DF (1996) Genetic variant near cytosolic phospholipase A2 associated with schizophrenia. Schizophr Res; 21(2):111–116
    Law MH, Cotton RGH, Berger GE (2006) The role of phospholipase A2 in schizophrenia. Mol Psychiatry 11:547–556
    Miller SA, Dykes DD, Polesky HF (1988) A single salting out procedure for extracting DNA from human nucleated cells. Nucl Acids Res 16:1215
    Ott J (1988) Utility programs for analysis of genetic linkage. Columbia University, New York
    Pae CU, Yu HS, Lee KU, Kim JJ, Lee CU, Lee SJ, Jun TY, Lee C, Paik IH (2004) BanI polymorphism of the cytosolic phospholipase A2 gene may confer susceptibility to the development of schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 28:739–741
    Peet M (1999) New strategies for the treatment of schizophrenia: omega-3 polyunsaturated fatty acids. In: Peet M, Glen I, Horronin DF (eds) Phospholipid spectrum disorder in psychiatriy. Marius Press, Carnforth, UK, pp 189–194
    Peet M, Ramchand CN, Lee J, Telang SD, Vankar GK, Shah S, Wei J (1998) Association of the BanI dimorphic site at the human cytosolic phospholipse A2 gene with schizophrenia. Psychiatr Genet 8:191–192
    Pettegrew JW, Keshavan MS, Panchalingan K, Strychor S, Kaplan DB, Tretta MG, Alen M (1991) Alterations in brain high-energy phosphate and membrane phospholipids metabolism in first-episode, drug naïve schizophrenics. Arc Gen Psychiatriy 48:563–568
    Price SA, Fox H, St Clair D, Shaw DJ (1997) Lack of association between schizophrenia and a polymorphism close to the cytosolic phospholipase A2 gene. Psychiatr Genet 7:111–114
    Rybakowski JK, Borkowska A, Czerski PM, Dmitrzak-Weglarz M, Hauser J (2003) The study of cytosolic phospholipase A2 gene polymorphism in schizophrenia using eye movement disturbances as an endophenotypic marker. Neuropsychobiology 47:115–119
    Smesny S, Kinder D, Willhardt I, Rosburg T, Lasch J, Berger G, Sauer H (2005) Increased calcium-independent phospholipase A2 activity in first but not multiepisode chronic schizophrenia. Biol Psychiatry 57:399–405
    Tao R, Yu Y, Zhang X, Guo Y, Shi J, Zhang X, Xie L, Liu S, Ju G, Xu Q, Shen Y, Wei J (2005) Cytosolic PLA2 genes possibly contribute to the etiology of schizophrenia. Am J Med Genet B Neuropsychiatr Genet 137(1):56–58
    Tavares H, Yacubian J, Talib LL, Barbosa NR, Gattaz WF (2003) Increased phospholipase A2 activity in schizophrenia with absent response to niacin. Schizophr Res 61:1–6
    Tay A, Simon JS, Squire J, Hamel K, Jacob HJ, Skorecki K (1995) Cytosolic phospholipase A2 gene in human and rat: chromosomal localization and polymorphic markers. Genomics 26:138–141
    Turetsky BI, Calkins ME, Light GA, Olincy A, Radant AD, Swerdlow NR (2007) Neurophysiological endophenotypes of schizophrenia: the viability of selected candidate measures. Schizophr Bull 1:69–94
    Wei J, Hemmings GP (2004) A study of a genetic association between the PTGS2/PLA2G4A locus and schizophrenia. Prostaglandins Leukot Essent Fatty Acids 70:413–415
    Wei J, Hemmings GP (2005) A study of the combined effect of the CLDN5 locus and the genes for the phospholipid metabolism pathway in schizophrenia. Prostaglandins Leukot Essent Fatty Acids 73(6):441–445
    Wei J, Lee KH, Hemmings GP (1998) Is the cPLA2 gene associated with schizophrenia? Mol Psychiatry 3:480–481
    Yu YQ, Tao R, Wei J, Xu Q, Liu SZ, Ju GZ, Shi JP, Zhang X, Xie L, Shen Y (2004) No association between the PTGS2/PLA2G4A locus and schizophrenia in a Chinese population. Prostaglandins Leukot Essent Fatty Acids 71:405–408